References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: 10.3322/caac.21660
- Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019; 14: 26–38. doi: 10.5114/pg.2018.80001
- Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet 2020; 396: 635–48. doi: 10.1016/s0140-6736(20)31288-5
- Lina X, Haiyanga Z, Boa Y, Haia H, Kea Z, Zoub K, et al. Plasma cell-free DNA for screening patients with benefit-assisted neoadjuvant chemotherapy for advanced gastric cancer. ScienceAsia 2020; 46: 462–71. doi: 10.2306/scienceasia1513-1874.2020.056
- Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer 2018; 21: 144–54. doi: 10.1007/s10120-017-0716-7
- Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell 1997; 88: 737–40. doi: 10.1016/s0092-8674(00)81918-2
- Miyagawa K, Tsuruga T, Kinomura A, Usui K, Katsura M, Tashiro S, et al. A role for RAD54B in homologous recombination in human cells. Embo J 2002; 21: 175–80. doi: 10.1093/emboj/21.1.175
- Yasuhara T, Suzuki T, Katsura M, Miyagawa K. Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. Nat Commun 2014; 5: 5426. doi: 10.1038/ncomms6426
- Zhang Z, Li X, Han Y, Ji T, Huang X, Gao Q, et al. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. Biomed Pharmacother 2019; 118: 109341. doi: 10.1016/j.biopha.2019.109341
- Feng S, Liu J, Hailiang L, Wen J, Zhao Y, Li X, et al. Amplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling. Transl Oncol 2021; 14: 101124. doi: 10.1016/j.tranon.2021.101124
- Xu C, Liu D, Mei H, Hu J, Luo M. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells. J Int Med Res 2019; 47: 5650–9. doi: 10.1177/0300060519869423
- Nagai Y, Yamamoto Y, Yasuhara T, Hata K, Nishikawa T, Tanaka T, et al. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Oncotarget 2015; 6: 21064–73. doi: 10.18632/oncotarget.4222
- Amaral T, Schulze M, Sinnberg T, Nieser M, Martus P, Battke F, et al. Are pathogenic germline variants in metastatic melanoma associated with resistance to combined immunotherapy? Cancers 2020; 12. doi: 10.3390/cancers12051101
- Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 2019; 47: W556–60. doi: 10.1093/nar/gkz430
- Deng T, Zhong P, Lou R, Yang, X. RNF220 promotes gastric cancer growth and stemness via modulating the USP22/wnt/β-catenin pathway. Tissue Cell 2023; 83: 102123. doi: 10.1016/j.tice.2023.102123
- Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018; 24: 2818–32. doi: 10.3748/wjg.v24.i26.2818
- McAndrew EN, McManus KJ. The enigmatic oncogene and tumor suppressor-like properties of RAD54B: Insights into genome instability and cancer. Genes Chromosomes Cancer 2017; 56: 513–23. doi: 10.1002/gcc.22458
- Wang M, Liao J, Tan C, Zhou H, Wang J, Wang K, et al. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B. J Cell Mol Med 2021; 25: 3327–38. doi: 10.1111/jcmm.16402
- Wang R, Li Y, Chen Y, Wang L, Wu Q, Guo Y, et al. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells. Oncol Rep 2018; 40: 1233–42. doi: 10.3892/or.2018.6522
- Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res 2010; 31: 158–75. doi: 10.1097/BCR.0b013e3181c7ed82
- Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–57. doi: 10.1038/35025220
- Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, et al. Tumor neovascularization and developments in therapeutics. Cancers 2019; 11. doi: 10.3390/cancers11030316
- Chatterjee A, Paul S, Bisht B, Bhattacharya S, Sivasubramaniam S, Paul MK. Advances in targeting the WNT/β-catenin signaling pathway in cancer. Drug Discov Today 2022; 27: 82–101. doi: 10.1016/j.drudis.2021.07.007
- Li TH, Zhao BB, Qin C, Wang YY, Li ZR, Cao HT, et al. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Cell Oncol 2021; 44: 1425–37. doi: 10.1007/s13402-021-00651-8
- Xueqin T, Jinhong M, Yuping H. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway. Bioengineered 2021; 12: 11567–75. doi: 10.1080/21655979.2021.1971028
- Yan Y, Zhang Y, Li M, Zhang Y, Zhang X, Zhang X, et al. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth. Cancer Sci 2021; 112: 4722–35. doi: 10.1111/cas.15118
- Song X, Wang S, Li L. New insights into the regulation of Axin function in canonical Wnt signaling pathway. Protein Cell 2014; 5: 186–93. doi: 10.1007/s13238-014-0019-2
- Machin P, Catasus L, Pons C, Muñoz J, Matias-Guiu X, Prat J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 2002; 33: 206–12. doi: 10.1053/hupa.2002.30723
- Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, et al. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 2001; 21: 1370–83. doi: 10.1128/mcb.21.4.1370-1383.2001
- Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033–8. doi: 10.1016/s0002-9440(10)65204-2